FOXM1 / DEPDC1 feedback loop promotes hepatocarcinogenesis and represents promising targets for cancer therapy
Cancer Science · 2024
DOI: 10.1111/cas.16273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Teng Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cytotherapy Laboratory, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern Un…. Hauptthemen laut MEDLINE: Forkhead Box Protein M1, Liver Neoplasms, Carcinoma, Hepatocellular, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jiangxi Provincial leading Talent of "Double Thousand Plan", Shenzhen International Collaborative Innovation Program, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Forkhead box M1 (FOXM1) is a key regulator of mitosis and is identified as an oncogene involved in several kinds of human malignancies. However, how it induces carcinogenesis and related therapeutic approaches remains not fully understood. In this study, we aimed to identify a regulatory axis involving FOXM1 and its target gene DEP domain containing 1 (DEPDC1) and investigate their biological functions. FOXM1 bound to the promoter and transcriptionally induced DEPDC1 expression, in turn, DEPDC1 physically interacted with FOXM1, promoted its nuclear translocation, and reinforced its transcriptional activities. The FOXM1/DEPDC1 axis was indispensable for cancer cells, as evidenced by the fact that DEPDC1 rescued cell growth inhibition caused by FOXM1 knockdown, and silencing DEPDC1 efficiently attenuated tumor growth in a murine hepatocellular carcinoma model. Furthermore, strong positive associations between FOXM1/DEPDC1 axis and poor clinical outcome were observed in human hepatocellular carcinoma samples, further indicating their significance for hepatocarcinogenesis. Finally, we attempted to exploit immunotherapy approaches to target the FOXM1/DEPDC1 axis. Several HLA‐A24:02‐restricted T‐cell epitopes targeting FOXM1 or DEPDC1 were identified through bioinformatic analysis. Then, T cell receptor (TCR)‐engineered T cells targeting FOXM1 262‐270 or DEPDC1 294‐302 were successfully established and proved to efficiently eradicate tumor cells. Our findings highlight the significance of the FOXM1/DEPDC1 axis in the process of oncogenesis and indicate their potential as immunotherapy targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cytotherapy Laboratory, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China.
- Department of Pathology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China.
- Jinan Key Laboratory of Medical Cell Bioengineering, Science and Technology Innovation Center, The Fourth People's Hospital of Jinan, The Teaching Hospital of Shandong First Medical University, Jinan, China.
- National Health Commission (NHC) Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou, China.
- Biomedicine Research Center, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
ORCID-Profile: Leisheng Zhang, Lili Ren
Förderung
- Jiangxi Provincial leading Talent of "Double Thousand Plan"
- Shenzhen International Collaborative Innovation Program
- Natural Science Foundation of Jiangxi Province
- Shenzhen Science and Technology Program
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Clinician Scientist Training Program of Shenzhen People's Hospital
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Wei, T., Zeng, C., Li, Q., Xiao, Z., Zhang, L., Zhang, Q., & Ren, L. (2024). FOXM1 / DEPDC1 feedback loop promotes hepatocarcinogenesis and represents promising targets for cancer therapy. Cancer Science. https://doi.org/10.1111/cas.16273
Vancouver
Wei T, Zeng C, Li Q, Xiao Z, Zhang L, Zhang Q, et al. FOXM1 / DEPDC1 feedback loop promotes hepatocarcinogenesis and represents promising targets for cancer therapy. Cancer Science. 2024. doi:10.1111/cas.16273
BibTeX
@article{Wei2024,
author = {Wei, Teng and Zeng, Chenquan and Li, Qineng and Xiao, Zhiyuan and Zhang, Leisheng and Zhang, Qiangnu and Ren, Lili},
title = {FOXM1 / DEPDC1 feedback loop promotes hepatocarcinogenesis and represents promising targets for cancer therapy},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16273}
}
EUVIMED